Etai Adam

Characteristics and risk factors of infections following CD28-based CD19 CAR-T cells

Talya Wittmann Dayagi, Gilad Sherman, Bella Bielorai et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2021 · 48 citations

Life Sciences, Hematology, Immunology +16

Treatment options for DOCK8 deficiency‐related severe dermatitis

Ayelet Ollech, Jacob Mashiah, Atar Lev et al. · The Journal of Dermatology · 2021 · 38 citations

Medicine, Dermatology, Immunology +17

Lessons Learned From Five Years of Newborn Screening for Severe Combined Immunodeficiency in Israel

Atar Lev, Idan Sharir, Amos J. Simon et al. · The Journal of Allergy and Clinical Immunology In Practice · 2022 · 29 citations

Medicine, Immunology, Pediatrics +14

Feasibility of leukapheresis for CAR T-cell production in heavily pre-treated pediatric patients

Daphna Hutt, Bella Bielorai, Bella Baturov et al. · Transfusion and Apheresis Science · 2020 · 27 citations

Medicine, Hematology, Pediatrics +14

Parameters of long‐term response with <scp>CD28</scp>‐based <scp>CD19 chimaeric antigen receptor‐modified</scp> T cells in children and young adults with <scp>B‐acute lymphoblastic leukaemia</scp>

Elad Jacoby, Bella Bielorai, Daphna Hutt et al. · British Journal of Haematology · 2022 · 26 citations

Medicine, Hematology, Immunology +17